The Chinese Biopharmaceutical Association (CBA) is a
non-profit organization made up of professionals who have an interest
in bio-pharmaceutical research and/or technology development. CBA was
established in 1995 and its headquarters are located in the State of
Maryland, which is adjacent to the U.S. capital city of Washington D.C.
The majority of CBA members are Chinese scientists, researchers, or
professors. They work in government agencies, universities, research
institutes as well as in the biotechnology and pharmaceutical
industries. Some are conducting pioneering research with the National
Institutes of Health (NIH), whereas others are directly involved in the
government regulatory process as officers of the Food and Drug
Administration (FDA) or in the field of intellectual property as patent
attorneys or as patent examiners with the Patent and Trademark Office
(PTO). CBA's Executive Committee consists of research, regulatory and
management professionals who, in aggregate, represent all sectors of
the bio-pharmaceutical research and development communities and the
industry’s regulatory agencies.
The Mission:
CBA is committed to promoting science, technology, and
business development in the bio-pharmaceutical fields through
information exchange and by fostering research and business
collaborations. It brings scientists and business practitioners
together and aims to establish links between basic and applied
research, between academia and industry, and between researchers and
entrepreneurs. CBA is also committed to facilitating all types of
biopharmaceutical-focused collaborations between the United States and
China.
CBA's
Approach:
CBA intends to accomplish its mission by serving as a liaison
between individual members for a myriad of scientific/technological and
business needs. The goal is to help to match up expert individual CBA
members with appropriate local institutes and companies that may be
able to provide needed technical and manufacturing needs. CBA also
hopes to provide a productive link between entrepreneurs and investors.
By serving as a conduit between the bio-pharmaceutical industries in
the United States and China CBA seeks to encourage the adoption of
advanced scientific knowledge and new innovative technologies to China
while also promoting business opportunities in both countries. CBA
members have expertise in all aspects of bio-pharmaceutical fields
ranging from expertise regarding recombinant DNA technology, large
scale protein production to gene therapy. Many of our members
thoroughly understand the FDA regulatory process and have hands-on
experience with implementation of GMP and GLP manufacturing processes,
various legal and legislative issues related to the commercial
development of diagnostic tests, medical devices and therapeutic drugs
as well as a range of business investment, financing, marketing and
management know-how. CBA members’ combined knowledge, skills and
experience constitutes a rich resource for the bio-pharmaceutical
industry sectors in both the U.S. and China.
About Shanghai Bio-Forum
Shanghai
International Biotechnology and Pharmaceutical Forum (Bio-Forum), which
is hosted by Modern Biotechnology & Pharmaceutical Industry Office
of Shanghai Municipality, has been successfully held each year since
the mid-1990s. With support from Ministry of Science & Technology
of the People’s Republic of China, State Food and Drug
Administration, State Administration of Traditional Chinese Medicine,
Science & Technology Commission of Shanghai Municipality,
Sino-American Pharmaceutical Professionals and the Chinese
Biopharmaceutical Association, Bio-Forum has progressively evolved into
an influential international conference focused in the fields of
biotechnology and pharmacy. It plays an important role in China’s
Biotech & Pharmaceutical scientific innovation and
industrialization.
The
Bio-Forum has attracted an increasing number of world-renowned
scientists, entrepreneurs and other outstanding specialists, including
academicians from US, Russia and China, senior presidents or vice
presidents of international pharmaceutical corporations such as Merck,
Novartis, Roche, Lilly, Bayer, Biogen, GlaxoSmithKline, financial and
investment experts from well-known biotech & pharmaceutical venture
capital corporations such as MPM, Lehman Brothers, Sofinnova, and
Toucan as well as senior officers and experts from SFDA, FDA, NIH, BIO,
US Pharmacopeia, England Development Agency, etc. The number of
attendees at the Bio-Forum has increased from 100 to above 500 during
the past decade; with more than one-fifth of registrants being
international participants.
Bio-Forum
is intended to provide a global forum for the exchange of information,
ideas and experience transcending geographical and economical barriers
to facilitate the interaction and cooperation among scientists and
entrepreneurs in the area of biotech & pharmaceutical industry. At
each Bio-Forum, the organizing committee sets the themes and subjects
according to hot topics and development trend of biotechnology &
pharmaceutical industry to keep a fresh perspective at the conference.
Seminars and round table conferences have been carried out involving
stem cell & tissue engineering, biochip & genome, genetically
engineered drugs & gene therapy, TCM modernization &
internalization, biophylaxis & SARS, newly formative infectious
disease & avian influenza, RNA interference & biotherapy, etc.
Moreover, parallel sessions or special subjects such as "Biotechnology
and pharmaceutical Entrepreneurs summit meeting", "Globalization and
generic drugs", "Intellectual Property Protection", "Outsourcing a CRO
service", "Venture Capital" “Global warming and environmental and
agricultural concerns” are organized to facilitate the
development of enterprises in seeking capital and cooperation
opportunities. In order to meet the needs of medium and small-scale
companies, Bio-Forum helps to make propagation and provide customized
services.
Bio-Forum
drives the biotech industry by bridging various organizations,
including start-ups, big companies, regional and national bioscience
associations, biotech centers and academic institutions. Not only
earned approval from academic circles, Bio-Forum has attracted
extensive attention from business and investment community. We welcome
attendees and delegations from all over the globe and we will make
efforts to deliver maximum value to all participants.
